Find uplifting stories about heroes, innovations, and solutions
7273 results for "peptide treatment"
Scientists are testing a naturally occurring peptide called MOTS-C that could help treat obesity by supercharging the body's cellular energy systems. The FDA is reviewing it for potential approval in 2026.
Scientists at UC San Diego discovered that catestatin, a naturally occurring peptide in our bodies, can slow melanoma growth and overcome drug resistance. This breakthrough could transform how doctors treat one of the deadliest forms of skin cancer.
A new once-daily pill just became the first FDA-approved oral peptide treatment for moderate-to-severe plaque psoriasis, offering hope to millions who've struggled with painful skin lesions. The breakthrough medication cleared or nearly cleared skin in 70% of patients during clinical trials.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A new HIV pill taken just once a week appears as effective as daily treatment in major studies. Over six million South Africans currently on daily HIV medication could benefit from simpler treatment.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
Researchers in Brazil discovered a naturally occurring peptide that protects brain cells from Parkinson's damage by targeting inflammation instead of just symptoms. The breakthrough could lead to treatments that actually slow the disease rather than mask its effects.
Patients with muscle-invasive bladder cancer now have the first major treatment breakthrough in over 20 years. A new drug combination keeps 80% of patients disease-free two years after treatment, compared to 66% with standard chemotherapy.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
Showing 20 of 7273